The Third Wave podcast takes a fresh look at the world of psychedelics, hearing the stories of people both in the psychedelic fringe and in mainstream society. We want to share how psychedelics are transforming the lives of people everywhere, both inside and outside of the psychedelic community.
In this episode of The Psychedelic Podcast, Paul F. Austin speaks with Kathryn L. Tucker, J.D., a leading civil rights attorney and advocate for end-of-life autonomy, about the legal effort to expand access to psilocybin-assisted therapy for patients facing serious illness.
Find full show notes and links here: https://thethirdwave.co/podcast/episode-353/?ref=278
Kathryn shares how decades of work in right-to-die litigation led her to recognize a critical gap in palliative care, addressing psychological and existential suffering at the end of life. Drawing from emerging clinical research, she explains why psilocybin may offer meaningful relief for anxiety, depression, and distress in terminal patients.
The conversation explores the legal pathways being pursued to make this treatment accessible, including Right to Try laws, federal litigation with the DEA, and efforts to reschedule psilocybin. Kathryn also reflects on the broader cultural and ethical implications of allowing individuals greater choice in how they approach death.
Kathryn L. Tucker, JD, is a nationally recognized leader in advancing improved care for seriously ill and dying patients. She has held leadership roles across multiple nonprofit organizations, including the National Psychedelics Association, the End of Life Liberty Project, and Compassion & Choices. Tucker has litigated landmark cases before the U.S. Supreme Court, including Washington v. Glucksberg and Vacco v. Quill, and has played a key role in both end-of-life litigation and psychedelic policy advocacy.
Highlights:
Episode Links:
Episode Sponsors:
Disclaimer: This content is for educational, informational, and entertainment purposes only. We do not promote or encourage the illegal use of any controlled substances. Nothing said here is medical or legal advice. Always consult a qualified medical or mental health professional before making decisions related to your health. The views expressed herein belong to the speaker alone, and do not reflect the views of any other person, company, or organization.
Third Wave occasionally partners with or shares information about other people, companies, and/or providers. While we work hard to only share information about ethical and responsible third parties, we can't and don't control the behavior of, products and services offered by, or the statements made by people, companies, or providers other than Third Wave. Accordingly, we encourage you to research for yourself, and consult a medical, legal, or financial professional before making decisions in those areas. Third Wave isn't responsible for the statements, conduct, services, or products of third parties. If we share a coupon code, we may receive a commission from sales arising from customers who use our coupon code. No one is required to use our coupon codes.
Healing Before Leading: Psychedelics and Political Integrity
In this episode of The Psychedelic Podcast, Paul F. Austin speaks with Laura Dunn, civil rights attorney and congressional candidate, about trauma, leadership, and the role of psychedelic healing.
Find full show notes and links here: https://thethirdwave.co/podcast/episode-352/?ref=278
Laura shares how her work advocating for survivors led her to confront the deeper limitations of legal and institutional systems. While policy change can create meaningful protections, it often fails to address the underlying trauma individuals carry.
They explore how psychedelic experiences became part of her personal healing journey, and how that informs her approach to leadership, public service, and political integrity.
Laura Dunn is an award-winning civil rights attorney, former public school teacher, and congressional candidate in New York's 12th District. She helped shape Title IX protections, contributed to the Violence Against Women Act reauthorization, and founded SurvJustice, a nonprofit supporting survivors of sexual violence. Her work bridges advocacy, policy, and trauma-informed leadership.
Highlights:
Episode Links:
Episode Sponsors:
Disclaimer: This content is for educational, informational, and entertainment purposes only. We do not promote or encourage the illegal use of any controlled substances. Nothing said here is medical or legal advice. Always consult a qualified medical or mental health professional before making decisions related to your health. The views expressed herein belong to the speaker alone, and do not reflect the views of any other person, company, or organization.
Third Wave occasionally partners with or shares information about other people, companies, and/or providers. While we work hard to only share information about ethical and responsible third parties, we can't and don't control the behavior of, products and services offered by, or the statements made by people, companies, or providers other than Third Wave. Accordingly, we encourage you to research for yourself, and consult a medical, legal, or financial professional before making decisions in those areas. Third Wave isn't responsible for the statements, conduct, services, or products of third parties. If we share a coupon code, we may receive a commission from sales arising from customers who use our coupon code. No one is required to use our coupon codes.
Western Philosophy on Drugs: Consciousness, Dreams, and Reality
In this episode of The Psychedelic Podcast, Paul F. Austin speaks with Dr. Justin Smith-Ruiu about how psychedelic experiences challenge long-standing assumptions about consciousness, perception, and reality.
Find full show notes and links here: https://thethirdwave.co/podcast/episode-351/?ref=278
Justin explains how Western philosophy has historically privileged rational, sober, and waking states of mind, often dismissing dreams and altered states as unreliable. He explores how psychedelic experiences push against these assumptions, raising deeper questions about knowledge, language, and what counts as real.
The conversation also examines the tension between therapeutic and existential uses of psychedelics, and how medicalization may shape the cultural role these substances play moving forward.
Justin Smith-Ruiu is a professor of history and philosophy of science at the Université Paris Cité and author of On Drugs: Psychedelics, Philosophy, and the Nature of Reality. His work explores intellectual history, consciousness, and the limits of rational thought, and he writes regularly for Harper's, WIRED, and The New York Times.
Highlights:
Episode Links:
Episode Sponsors:
Disclaimer: This content is for educational, informational, and entertainment purposes only. We do not promote or encourage the illegal use of any controlled substances. Nothing said here is medical or legal advice. Always consult a qualified medical or mental health professional before making decisions related to your health. The views expressed herein belong to the speaker alone, and do not reflect the views of any other person, company, or organization.
Third Wave occasionally partners with or shares information about other people, companies, and/or providers. While we work hard to only share information about ethical and responsible third parties, we can't and don't control the behavior of, products and services offered by, or the statements made by people, companies, or providers other than Third Wave. Accordingly, we encourage you to research for yourself, and consult a medical, legal, or financial professional before making decisions in those areas. Third Wave isn't responsible for the statements, conduct, services, or products of third parties. If we share a coupon code, we may receive a commission from sales arising from customers who use our coupon code. No one is required to use our coupon codes.
Can Ketamine Help Benzodiazepine Withdrawal? - Melissa Bond & Dr. Amy de la Garza
In this episode of The Psychedelic Podcast, Paul F. Austin speaks with Melissa Bond and Dr. Amy de la Garza about the hidden risks of benzodiazepines, the reality of dependency, and what recovery can require.
Find full show notes and links here: https://thethirdwave.co/podcast/episode-350/?ref=278
Melissa shares her experience of becoming dependent on prescribed medication, and the physical and emotional challenges of withdrawal. Dr. de la Garza brings a clinical perspective, explaining how benzodiazepines affect the nervous system and why withdrawal can be prolonged and destabilizing.
The conversation also looks at where conventional care often falls short, and how more integrative approaches are beginning to emerge. This includes the use of low-dose ketamine as a potential tool to support the nervous system during withdrawal, particularly in more complex or prolonged cases.
Melissa Bond is a narrative journalist and poet. Her memoir Blood Orange Night, which chronicles her experience with benzodiazepine dependency, was published by Simon & Schuster and recognized by The New York Times as one of the best audiobooks of 2022. Her work has appeared on PBS, The New York Times Podcast, RadioWest, and TEDx. Dr. Amy de la Garza is a board-certified physician in Family and Addiction Medicine, a certified Functional Medicine practitioner, and co-founder of Nosis Health, a virtual outpatient addiction medicine platform. Her work integrates functional, lifestyle, and emerging therapies, including ketamine-assisted treatment, to support recovery.
Highlights:
Episode Links:
Episode Sponsors:
Disclaimer: This content is for educational, informational, and entertainment purposes only. We do not promote or encourage the illegal use of any controlled substances. Nothing said here is medical or legal advice. Always consult a qualified medical or mental health professional before making decisions related to your health. The views expressed herein belong to the speaker alone, and do not reflect the views of any other person, company, or organization.
Third Wave occasionally partners with or shares information about other people, companies, and/or providers. While we work hard to only share information about ethical and responsible third parties, we can't and don't control the behavior of, products and services offered by, or the statements made by people, companies, or providers other than Third Wave. Accordingly, we encourage you to research for yourself, and consult a medical, legal, or financial professional before making decisions in those areas. Third Wave isn't responsible for the statements, conduct, services, or products of third parties. If we share a coupon code, we may receive a commission from sales arising from customers who use our coupon code. No one is required to use our coupon codes.
In this episode of The Psychedelic Podcast, Paul F. Austin speaks with a molecular geneticist exploring what it could look like to rethink how psychedelic medicines are sourced at a fundamental level.
Find full show notes and links here: https://thethirdwave.co/podcast/episode-349/?ref=278
Jeffrey Gerst explains how his work in RNA biology and gene expression has led him to explore bioengineering as a way to produce psychedelic compounds without relying on wild harvesting or traditional chemical synthesis.
The conversation looks at how cells organize and communicate, and how those same biological principles could be used to create more sustainable and scalable systems for medicine production. Paul and Jeff also reflect on the broader implications of this shift, from environmental stewardship to the long-term integrity of the psychedelic ecosystem.
Professor Jeffrey Gerst is a molecular geneticist and Full Professor at the Weizmann Institute of Science, where he studies how cells regulate gene expression through RNA trafficking and localized protein synthesis.
His research has advanced understanding of how mRNA moves within and between cells, revealing new forms of cellular communication and potential applications in therapeutic delivery. More recently, his work has expanded into the bioengineering of psychedelic compounds, with a focus on developing sustainable, scalable, and ethical methods of production. Highlights:
Episode Links:
Episode Sponsors:
Disclaimer: This content is for educational, informational, and entertainment purposes only. We do not promote or encourage the illegal use of any controlled substances. Nothing said here is medical or legal advice. Always consult a qualified medical or mental health professional before making decisions related to your health. The views expressed herein belong to the speaker alone, and do not reflect the views of any other person, company, or organization.
Third Wave occasionally partners with or shares information about other people, companies, and/or providers. While we work hard to only share information about ethical and responsible third parties, we can't and don't control the behavior of, products and services offered by, or the statements made by people, companies, or providers other than Third Wave. Accordingly, we encourage you to research for yourself, and consult a medical, legal, or financial professional before making decisions in those areas. Third Wave isn't responsible for the statements, conduct, services, or products of third parties. If we share a coupon code, we may receive a commission from sales arising from customers who use our coupon code. No one is required to use our coupon codes.
Herbal Ecstasy & The Billion Dollar Smart Drug Boom
In this episode of The Psychedelic Podcast, Paul F. Austin sits down with entrepreneur Shaahin Cheyene, creator of the controversial 1990s supplement "Herbal Ecstasy," which helped launch the legal smart-drug movement.
Find full show notes and links here: https://thethirdwave.co/podcast/episode-348/?ref=278
Shaahin shares how he built a multimillion-dollar business at just fifteen by creating a legal herbal alternative to MDMA during a shortage in the rave scene.
The conversation explores 1990s rave culture, the ethics of prohibition, and how natural supplements intersect with psychedelics, entrepreneurship, and personal freedom. They also discuss his later ventures in Amazon commerce, podcast media, and YouTube.
Shaahin Cheyene is the creator of Herbal Ecstasy, a supplement that helped spark the legal smart-drug movement in the 1990s. He built the business as a teenager into a multimillion-dollar company.
Over the past three decades, Shaahin has become an award-winning entrepreneur, Amazon expert, inventor, author, and filmmaker whose ventures have generated over a billion dollars in revenue. He is the founder of PodcastCola and Viral Mirage.
Through his businesses, Shaahin continues to mentor entrepreneurs and develop health and wellness products focused on optimizing human performance.
Highlights:
Episode Links:
Episode Sponsors:
Disclaimer: This content is for educational, informational, and entertainment purposes only. We do not promote or encourage the illegal use of any controlled substances. Nothing said here is medical or legal advice. Always consult a qualified medical or mental health professional before making decisions related to your health. The views expressed herein belong to the speaker alone, and do not reflect the views of any other person, company, or organization.
Third Wave occasionally partners with or shares information about other people, companies, and/or providers. While we work hard to only share information about ethical and responsible third parties, we can't and don't control the behavior of, products and services offered by, or the statements made by people, companies, or providers other than Third Wave. Accordingly, we encourage you to research for yourself, and consult a medical, legal, or financial professional before making decisions in those areas. Third Wave isn't responsible for the statements, conduct, services, or products of third parties. If we share a coupon code, we may receive a commission from sales arising from customers who use our coupon code. No one is required to use our coupon codes.
In this episode of The Psychedelic Podcast, Paul F. Austin speaks with Jonathan Dickinson, CEO and Co-Founder of Ambio Life Sciences, about the evolving role of ibogaine in psychedelic medicine.
Listen to the full episode: https://thethirdwave.co/podcast/episode-347/?ref=278
Jonathan shares his path from leading the Global Ibogaine Therapy Alliance to helping build one of the field's most prominent ibogaine treatment organizations. Together they explore ibogaine's expanding therapeutic potential for traumatic brain injury, addiction, and neurological conditions, along with the clinical realities of delivering this powerful medicine safely.
They also discuss the challenges of scaling ibogaine treatment, the importance of preparation and integration, and how traditional Bwiti knowledge from Gabon continues to shape ethical and culturally grounded approaches to this work.
Jonathan Dickinson is the CEO and Co-Founder of Ambio Life Sciences and a leading expert on ibogaine therapy. With more than 15 years of experience in psychedelic research, clinical care, and traditional practice, he has helped shape global safety standards for ibogaine treatment.
A Mexico-licensed psychologist and former Executive Director of the Global Ibogaine Therapy Alliance, Jonathan has published research on ibogaine's therapeutic potential for trauma, traumatic brain injury, and neurological conditions. He has also been initiated into the Bwiti traditions of Gabon and holds a Nagoya-compliant export license for Tabernanthe iboga root.
Highlights:
In this episode of The Psychedelic Podcast, Paul F. Austin speaks with Christopher Solomon, founder of Salvia Healings, about how Salvia divinorum can be approached as a therapeutic and introspective tool when used with preparation and somatic awareness.
Find full show notes and links here: https://thethirdwave.co/podcast/episode-346/?ref=278
They discuss dosage, harm reduction, and the importance of building a supportive container for working with intense altered states. The conversation explores how somatic awareness, breath, and pacing can help transform the Salvia experience into an opportunity for meditation, trauma processing, and self guided healing.
Christopher Solomon is a somatic Salvia guide and educator focused on helping people approach Salvia with safety, structure, and intention. Drawing from his training in somatic psychotherapy, he teaches how to work with this powerful plant in ways that support introspection and personal growth.
Highlights:
Episode Links:
Episode Sponsors:
Third Wave occasionally partners with or shares information about other people, companies, and/or providers. While we work hard to only share information about ethical and responsible third parties, we can't and don't control the behavior of, products and services offered by, or the statements made by people, companies, or providers other than Third Wave. Accordingly, we encourage you to research for yourself, and consult a medical, legal, or financial professional before making decisions in those areas. Third Wave isn't responsible for the statements, conduct, services, or products of third parties. If we share a coupon code, we may receive a commission from sales arising from customers who use our coupon code. No one is required to use our coupon codes."
In this episode of The Psychedelic Podcast, Paul F. Austin speaks with Jodi Lomask, an artist, choreographer, and creative guide whose work bridges art, science, embodiment, and psychedelic experience.
Find full show notes and links here: https://thethirdwave.co/podcast/episode-345/?ref=278
They explore how psychedelic experiences can be approached as acts of creative design shaped by context and environment. Jodi shares insights from decades of immersive performance work and discusses flow, embodied intelligence, psychological safety in groups, and the differences between microdosing and vision quests.
Jodi Lomask is an artist and founder of Capacitor, a performance company exploring the intersection of dance, science, and consciousness. Through Creative Journey, she supports individuals and teams in cultivating creative flow and embodied insight.
Highlights:
Episode Links:
Episode Sponsors:
Disclaimer: This content is for educational, informational, and entertainment purposes only. We do not promote or encourage the illegal use of any controlled substances. Nothing said here is medical or legal advice. Always consult a qualified medical or mental health professional before making decisions related to your health. The views expressed herein belong to the speaker alone, and do not reflect the views of any other person, company, or organization.
Third Wave occasionally partners with or shares information about other people, companies, and/or providers. While we work hard to only share information about ethical and responsible third parties, we can't and don't control the behavior of, products and services offered by, or the statements made by people, companies, or providers other than Third Wave. Accordingly, we encourage you to research for yourself, and consult a medical, legal, or financial professional before making decisions in those areas. Third Wave isn't responsible for the statements, conduct, services, or products of third parties. If we share a coupon code, we may receive a commission from sales arising from customers who use our coupon code. No one is required to use our coupon codes.
In this episode of The Psychedelic Podcast, Paul F. Austin speaks with Hunt Priest, founder of Ligare, about Christianity, mysticism, and the ethical integration of psychedelic experience within spiritual life.
Find full show notes and links here: https://thethirdwave.co/podcast/episode-344/?ref=278
They discuss Hunt's participation in a 2016 Johns Hopkins psilocybin study for clergy, Christianity's long history of mystical experience, and how non-ordinary states can be held within ethical and communal containers. The conversation also explores legality versus ethics, justice and institutional risk, and how psychedelics relate to prayer, meditation, and service within a broader spiritual life.
Hunt Priest is a Christian minister and founder of Ligare, a nonprofit exploring the relationship between Christianity and psychedelics. Formerly an Episcopal priest, he works at the intersection of spiritual formation, ethics, and community-based integration of mystical experience.
Highlights:
Episode Links:
Episode Sponsors:
Disclaimer: This content is for educational, informational, and entertainment purposes only. We do not promote or encourage the illegal use of any controlled substances. Nothing said here is medical or legal advice. Always consult a qualified medical or mental health professional before making decisions related to your health. The views expressed herein belong to the speaker alone, and do not reflect the views of any other person, company, or organization.
Third Wave occasionally partners with or shares information about other people, companies, and/or providers. While we work hard to only share information about ethical and responsible third parties, we can't and don't control the behavior of, products and services offered by, or the statements made by people, companies, or providers other than Third Wave. Accordingly, we encourage you to research for yourself, and consult a medical, legal, or financial professional before making decisions in those areas. Third Wave isn't responsible for the statements, conduct, services, or products of third parties. If we share a coupon code, we may receive a commission from sales arising from customers who use our coupon code. No one is required to use our coupon codes.
In this episode of The Psychedelic Podcast, Paul F. Austin speaks with Justin Wolf, co-founder and CEO of New Brew, about plant-based alternatives to alcohol and how social drinking culture may be shifting.
Find full show notes and links here: https://thethirdwave.co/podcast/episode-343/?ref=278
Justin shares how exploring kava and kratom traditions in Mexico shaped New Brew's approach to formulation, emphasizing reliable dosing, transparency, and harm reduction. Together, they discuss why alcohol became the default social drug, the limits of most "functional beverages," and the nuance behind terms like "Cali sober."
The conversation also explores dependency risk, intention, moderation, and why plant-based alternatives are not positioned for those pursuing full abstinence. At its core, this episode is about expanding optionality and building new social rituals responsibly.
Justin Wolf is the co-founder and CEO of New Brew, a plant-powered social tonic designed as an alternative to alcohol. Prior to launching New Brew, Justin spent five years leading Global Partnerships at Google and helped launch DripDrop, an electrolyte hydration brand now sold nationwide. Inspired by kava and kratom traditions he encountered in Mexico, he founded New Brew with a focus on transparency, education, and harm reduction. He is also an early investor and advisor in the psychedelic medicine
Highlights:
Episode Link:
Episode Sponsors:
Disclaimer: This content is for educational, informational, and entertainment purposes only. We do not promote or encourage the illegal use of any controlled substances. Nothing said here is medical or legal advice. Always consult a qualified medical or mental health professional before making decisions related to your health. The views expressed herein belong to the speaker alone, and do not reflect the views of any other person, company, or organization.
Third Wave occasionally partners with or shares information about other people, companies, and/or providers. While we work hard to only share information about ethical and responsible third parties, we can't and don't control the behavior of, products and services offered by, or the statements made by people, companies, or providers other than Third Wave. Accordingly, we encourage you to research for yourself, and consult a medical, legal, or financial professional before making decisions in those areas. Third Wave isn't responsible for the statements, conduct, services, or products of third parties. If we share a coupon code, we may receive a commission from sales arising from customers who use our coupon code. No one is required to use our coupon codes.